SCHEMBL672096

SCHEMBL672096

O=[PH](OC1CCC1)OC1CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL673922 0.94 CA1 (0.35)
SCHEMBL673199 0.91 CA1 (0.39)
SCHEMBL4453883 0.87
SCHEMBL15941586 0.77
SCHEMBL673840 0.76 CA1 (0.33)
Water SCHEMBL7648266 0.75 ACHE (0.32)
SCHEMBL10785137 0.73 CA1 (0.31)
SCHEMBL24862596 0.71 EPHX1 (0.36)
SCHEMBL3066085 0.71 CA1 (0.37)
SCHEMBL8435994 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025233849-A2 MAPT siRNA AND USES THEREOF JANSSEN PHARMACEUTICA NV (BE) 2025-11-13 WO disclosed
WO-2025052316-A1 SNCA siRNA AND USES THEREOF JANSSEN PHARMACEUTICA NV (BE) 2025-03-13 WO disclosed
EP-4493691-A2 MAPT SIRNA AND USES THEREOF JANSSEN Pharmaceutica NV (BE) 2025-01-22 EP disclosed
WO-2023175091-A2 MAPT siRNA AND USES THEREOF JANSSEN PHARMACEUTICA NV (BE) 2023-09-21 WO disclosed
WO-2014124430-A1 NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO EMORY UNIVERSITY (US) 2014-08-14 WO disclosed
US-20120252979-A1 Process for Producing Blends of Syndiotactic, 1,2-Polybutadiene and Rubbery Elastomers RADEMACHER CHRISTINE (US) 2012-10-04 US disclosed
US-8067503-B2 Process for producing blends of syndiotactic, 1,2-polybutadiene and rubbery elastomers BRIDGESTONE CORPORATION (JP) 2011-11-29 US disclosed
EP-1476480-B1 POLYMERIZATION PROCESS FOR PREPARING SYNDIOTACTIC 1,2-POLYBUTADIENE BRIDGESTONE CORP (JP) 2009-07-22 EP disclosed
EP-0994128-B1 Process and iron-based catalyst composition for the production of syndiotactic 1,2-polybutadiene BRIDGESTONE CORP (JP) 2007-08-01 EP disclosed
US-20070161748-A1 PROCESS FOR PRODUCING BLENDS OF SYNDIOTACTIC, 1,2-POLYBUTADIENE AND RUBBERY ELASTOMERS BRIDGESTONE CORPORATION 2007-07-12 US disclosed
WO-2001032724-A1 IRON-BASED CATALYST FOR PRODUCING OLIGOMERS OF CONJUGATED DIENES BRIDGESTONE CORPORATION (JP) 2001-05-10 WO disclosed
US-6211313-B1 COORDINATION COMPOUND OF IRON CONTAINING COMPOUND, PHOSPHITE AND ORGANOALUMINUM COMPOUND BRIDGESTONE CORPORATION (JP) 2001-04-03 US disclosed
US-6201080-B1 CATALYTIC POLYMERIZATION OF BUTADIENE IN A SOLVENT BRIDGESTONE CORPORATION (JP) 2001-03-13 US disclosed
US-6197888-B1 FORMED BY COMBINING AN IRON-CONTAINING COMPOUND, A HYDROGEN PHOSPHITE, AND AN ORGANOALUMINUM COMPOUND. BRIDGESTONE CORPORATION (JP) 2001-03-06 US disclosed
WO-2000075201-A1 MOLYBDENUM-BASED CATALYST COMPOSITION FOR POLYMERIZING CONJUGATED DIENES BRIDGESTONE CORPORATION (JP) 2000-12-14 WO disclosed
EP-0994127-A1 Method of preparing syndiotactic 1,2-polybutadiene with a chromium-based catalyst system Bridgestone Corporation (JP) 2000-04-19 EP disclosed
EP-0994129-A1 Iron-based catalyst composition and process for producing syndiotactic 1,2-polybutadiene Bridgestone Corporation (JP) 2000-04-19 EP disclosed
EP-0994128-A1 Process and iron-based catalyst composition for the production of syndiotactic 1,2-polybutadiene Bridgestone Corporation (JP) 2000-04-19 EP disclosed
US-5919875-A ORGANOALUMINUM HYDRIDE, ORGANIC HYDROGEN PHOSPHITE BRIDGESTONE CORPORATION (JP) 1999-07-06 US disclosed
EP-0926167-A1 Preparation of syndiotactic 1,2-polybutadiene using a chromium-containing catalyst system Bridgestone Corporation (JP) 1999-06-30 EP disclosed